Interaction of a novel GDP exchange inhibitor with the Ras protein

A K Ganguly1, Y S Wang, B N Pramanik

  • 1Agouron Pharmaceuticals, San Diego, California 92121, USA.

Biochemistry
|December 8, 1998
PubMed

Insights

A novel inhibitor (SCH-54292) targets mutated Ras proteins, crucial in many cancers. Low magnesium reveals Ras protein conformational changes, enhancing inhibitor binding for potential cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Mutated Ras proteins are implicated in various human cancers.
  • Targeting Ras function with inhibitors offers a potential therapeutic strategy for Ras-related tumors.

Purpose of the Study:

  • To investigate the interaction between a novel GDP exchange inhibitor (SCH-54292) and the Ras-GDP protein.
  • To elucidate the conformational changes in Ras protein at low Mg2+ concentrations and their effect on inhibitor binding.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy, specifically 2D 1H-15N HSQC experiments.
  • Studying the Ras-GDP protein in the presence of SCH-54292 and varying Mg2+ concentrations.
  • Deriving a structural model of the inhibitor-Ras-GDP complex using NOE distance constraints.

Main Results:

  • Inhibitor binding to Ras-GDP was enhanced at low Mg2+ concentrations, facilitating stable complex formation for NMR studies.
  • Ras protein exhibited two conformations in slow exchange at low Mg2+, involving the GDP binding pocket, switch I, and switch II regions.
  • These conformational changes were reversible upon addition of excess Mg2+.
  • The inhibitor was found to bind to the critical switch II region of the Ras protein.

Conclusions:

  • Low Mg2+ concentrations induce conformational changes in Ras protein, enhancing the binding of the SCH-54292 inhibitor.
  • The inhibitor targets the switch II region, a key area for Ras protein function.
  • Understanding these interactions provides insights for developing targeted therapies against Ras-driven cancers.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...